EW Stock: Technical Signals Remain Intact

The S&P 500 is flat on the year, but it sure doesn't feel that way. This has been a difficult market to navigate in 2018, due to the elevated levels of volatility, but that does not mean there are not still pockets of strength out there.
I am returning to focus on Edwards Lifesciences Corp (NYSE:EW) stock because I want to point out that even though the EW stock price suffered a slight setback after its earnings announcement, the downward pressure has done little to negate the bullish implications that I outlined on March 19, 2018, in a publication titled "This Is Why Edwards Lifesciences Stock Is Geared Toward Higher Prices."
In fact, the price action remains quite constructive, and as long as the EW stock price does not trade back within the price pattern that first initiated my bullish view, then the bullish implications suggested by it remain intact, and a move toward higher Edwards Lifesciences stock prices is still in development.
The price pattern I am referring to is highlighted on the following Edwards Lifesciences stock chart.
Chart courtesy of StockCharts.com
The technical price pattern highlighted on the EW stock chart is a cup-and-handle pattern.
These patterns are characterized by two distinct troughs, where the first is much larger than the second. The troughs are created because a significant level of price resistance prevents the stock price from advancing beyond it. In this case, resistance resided at $122.00.
The completion of this pattern implied that higher EW stock prices were likely to prevail, which is where my bullish view originated from.
After this pattern was completed, Edwards Lifesciences stock appreciated by 14.26% before a correction ensued. This correction gathered speed after earnings were released and it caused EW stock to test the level of price resistance that was responsible for creating the cup-and-handle price pattern.
Returning to test a previous level of price resistance after a breakout is called a backtest. A backtest serves to reaffirm that the original break above resistance was legitimate while simultaneously establishing this price point as a new level of price support.
As long as Edwards Lifesciences stock remains above this price point, the bullish implications suggested by the completed cup-and-handle price pattern stay intact.
The implications suggested by the completed pattern and the price action that follow are magnified when combined with the price action that preceded it.
This entire package of price action is highlighted on the following Edwards Lifesciences stock chart.
Chart courtesy of StockCharts.com
This stock chart highlights the wave structure and an influential momentum indicator that has been responsible for creating the bullish trend in EW stock.
This wave structure consists of alternating waves, which include impulse waves and consolidation waves.
The waves highlighted in green are impulse waves, and they define the period in a bullish trend when a stock stages a sustained move toward higher prices.
The waves highlighted in purple are consolidation waves, and they define the period in a bullish trend when the stock price corrects and refrains from advancing.
The cup-and-handle price pattern is a consolidation wave. A bullish trend cannot be created without a consolidation wave because they create the necessary conditions where a new advancing impulse wave can follow.
The completion of the consolidation wave implies that an impulse wave is in development and that higher Edwards Lifesciences stock prices are likely. The sell-off that followed earnings has done nothing to suggest otherwise.
This notion of the development of higher prices is still being reinforced by the moving average convergence/divergence (MACD) indicator.
MACD is a very influential momentum indicator that uses the crossing of a signal line to distinguish whether bullish or bearish momentum is influencing the price action in a stock.
Bullish momentum implies that a stock is geared toward higher prices, while a bearish momentum implies that a stock is geared toward lower prices. The reason why this is an influential indicator is because a stock cannot sustain a move in either direction unless the applicable momentum is supporting it.
A testament to this statement is that every bullish MACD cross has coincided with an impulse wave, and every bearish MACD cross has coincided with a consolidation wave.
A bullish MACD cross was created in January, supporting the notion that an impulse wave is currently in development, and the sell-off that followed earnings has done little to negate this signal. Therefore, higher Edwards Lifesciences stock prices are still expected.

Analyst Take

I am still bullish on Edwards Lifesciences stock, and the sell-off that followed earnings has done little to negate the bullish indications that were responsible for creating my bullish view on EW stock in the first place.

Despite the Sell-Off, Edwards Life Sciences Stock Still Remains Bullish

By Patrick Brik, BAS, CFA, CMT Published : April 30, 2018

iStock.com/gopixa

EW Stock: Technical Signals Remain Intact

The S&P 500 is flat on the year, but it sure doesn’t feel that way. This has been a difficult market to navigate in 2018, due to the elevated levels of volatility, but that does not mean there are not still pockets of strength out there.

I am returning to focus on Edwards Lifesciences Corp (NYSE:EW) stock because I want to point out that even though the EW stock price suffered a slight setback after its earnings announcement, the downward pressure has done little to negate the bullish implications that I outlined on March 19, 2018, in a publication titled “This Is Why Edwards Lifesciences Stock Is Geared Toward Higher Prices.”

In fact, the price action remains quite constructive, and as long as the EW stock price does not trade back within the price pattern that first initiated my bullish view, then the bullish implications suggested by it remain intact, and a move toward higher Edwards Lifesciences stock prices is still in development.

The price pattern I am referring to is highlighted on the following Edwards Lifesciences stock chart.

The technical price pattern highlighted on the EW stock chart is a cup-and-handle pattern.

These patterns are characterized by two distinct troughs, where the first is much larger than the second. The troughs are created because a significant level of price resistance prevents the stock price from advancing beyond it. In this case, resistance resided at $122.00.

The completion of this pattern implied that higher EW stock prices were likely to prevail, which is where my bullish view originated from.

After this pattern was completed, Edwards Lifesciences stock appreciated by 14.26% before a correction ensued. This correction gathered speed after earnings were released and it caused EW stock to test the level of price resistance that was responsible for creating the cup-and-handle price pattern.

Returning to test a previous level of price resistance after a breakout is called a backtest. A backtest serves to reaffirm that the original break above resistance was legitimate while simultaneously establishing this price point as a new level of price support.

As long as Edwards Lifesciences stock remains above this price point, the bullish implications suggested by the completed cup-and-handle price pattern stay intact.

The implications suggested by the completed pattern and the price action that follow are magnified when combined with the price action that preceded it.

This entire package of price action is highlighted on the following Edwards Lifesciences stock chart.

This stock chart highlights the wave structure and an influential momentum indicator that has been responsible for creating the bullish trend in EW stock.

This wave structure consists of alternating waves, which include impulse waves and consolidation waves.

The waves highlighted in green are impulse waves, and they define the period in a bullish trend when a stock stages a sustained move toward higher prices.

The waves highlighted in purple are consolidation waves, and they define the period in a bullish trend when the stock price corrects and refrains from advancing.

The cup-and-handle price pattern is a consolidation wave. A bullish trend cannot be created without a consolidation wave because they create the necessary conditions where a new advancing impulse wave can follow.

The completion of the consolidation wave implies that an impulse wave is in development and that higher Edwards Lifesciences stock prices are likely. The sell-off that followed earnings has done nothing to suggest otherwise.

This notion of the development of higher prices is still being reinforced by the moving average convergence/divergence (MACD) indicator.

MACD is a very influential momentum indicator that uses the crossing of a signal line to distinguish whether bullish or bearish momentum is influencing the price action in a stock.

Bullish momentum implies that a stock is geared toward higher prices, while a bearish momentum implies that a stock is geared toward lower prices. The reason why this is an influential indicator is because a stock cannot sustain a move in either direction unless the applicable momentum is supporting it.

A testament to this statement is that every bullish MACD cross has coincided with an impulse wave, and every bearish MACD cross has coincided with a consolidation wave.

A bullish MACD cross was created in January, supporting the notion that an impulse wave is currently in development, and the sell-off that followed earnings has done little to negate this signal. Therefore, higher Edwards Lifesciences stock prices are still expected.

Analyst Take

I am still bullish on Edwards Lifesciences stock, and the sell-off that followed earnings has done little to negate the bullish indications that were responsible for creating my bullish view on EW stock in the first place.

Dear Reader: There is no magic formula to getting rich. Success in investment vehicles with the best prospects for price appreciation can only be achieved through proper and rigorous research and analysis. We are 100% independent in that we are not affiliated with any bank or brokerage house. Information contained herein, while believed to be correct, is not guaranteed as accurate. Warning: Investing often involves high risks and you can lose a lot of money. Please do not invest with money you cannot afford to lose. The opinions in this content are just that, opinions of the authors. We are a publishing company and the opinions, comments, stories, reports, advertisements and articles we publish are for informational and educational purposes only; nothing herein should be considered personalized investment advice. Before you make any investment, check with your investment professional (advisor). We urge our readers to review the financial statements and prospectus of any company they are interested in. We are not responsible for any damages or losses arising from the use of any information herein. Past performance is not a guarantee of future results. All registered trademarks are the property of their respective owners.